Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 4 | 1 |
| List of Figures | 4 | 1 |
| Biocon Limited Snapshot | 5 | 1 |
| Biocon Limited Overview | 5 | 1 |
| Key Facts | 5 | 1 |
| Biocon Limited Research and Development Overview | 6 | 3 |
| Key Therapeutic Areas | 6 | 3 |
| Biocon Limited Pipeline Review | 9 | 4 |
| Pipeline Products by Stage of Development | 9 | 1 |
| Pipeline Products Monotherapy | 10 | 1 |
| Pipeline Products Partnered Products | 11 | 1 |
| Partnered Products/Combination Treatment Modalities | 12 | 1 |
| Biocon Limited Pipeline Products Glance | 13 | 5 |
| Biocon Limited Late Stage Pipeline Products | 13 | 1 |
| Pre-Registration Products/Combination Treatment Modalities | 13 | 1 |
| Phase III Products/Combination Treatment Modalities | 14 | 1 |
| Biocon Limited Clinical Stage Pipeline Products | 15 | 1 |
| Phase II Products/Combination Treatment Modalities | 15 | 1 |
| Phase I Products/Combination Treatment Modalities | 16 | 1 |
| Biocon Limited Early Stage Pipeline Products | 17 | 1 |
| Preclinical Products/Combination Treatment Modalities | 17 | 1 |
| Biocon Limited Drug Profiles | 18 | 18 |
| adalimumab biosimilar Drug Profile | 18 | 1 |
| bevacizumab biosimilar Drug Profile | 19 | 1 |
| BVX-20 Drug Profile | 20 | 1 |
| etanercept biosimilar Drug Profile | 21 | 1 |
| filgrastim Drug Profile | 22 | 1 |
| insulin aspart Drug Profile | 23 | 1 |
| insulin glargine Drug Profile | 24 | 2 |
| insulin human Drug Profile | 26 | 1 |
| insulin lispro Drug Profile | 27 | 1 |
| insulin tregopil Drug Profile | 28 | 2 |
| itolizumab Drug Profile | 30 | 2 |
| Monoclonal Antibody Conjugates for Oncology and Infectious Disease Drug Profile | 32 | 1 |
| pegfilgrastim Drug Profile | 33 | 1 |
| trastuzumab biosimilar Drug Profile | 34 | 2 |
| Biocon Limited Pipeline Analysis | 36 | 6 |
| Biocon Limited Pipeline Products by Target | 36 | 2 |
| Biocon Limited Pipeline Products by Route of Administration | 38 | 1 |
| Biocon Limited Pipeline Products by Molecule Type | 39 | 1 |
| Biocon Limited Pipeline Products by Mechanism of Action | 40 | 2 |
| Biocon Limited Dormant Projects | 42 | 1 |
| Biocon Limited Company Statement | 43 | 5 |
| Biocon Limited Locations And Subsidiaries | 48 | 2 |
| Head Office | 48 | 1 |
| Other Locations &Subsidiaries | 48 | 2 |
| Appendix | 50 | 2 |
| Methodology | 50 | 1 |
| Coverage | 50 | 1 |
| Secondary Research | 50 | 1 |
| Primary Research | 50 | 1 |
| Expert Panel Validation | 50 | 1 |
| Contact Us | 50 | 1 |
| Disclaimer | 51 | 1 |